Cormorant Asset Management, LP - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...6, 7, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
1:30 pm
Purchase
2026-03-3113GRALLYBIO CORP COM
RLYB
Cormorant Asset Management, LP400,000
7.560%
400,000increase
(New Position)
Filing
History
2026-05-15
1:28 pm
Sale
2026-03-3113GRAPPORT THERAPEUTICS INC
RAPP
Cormorant Asset Management, LP2,957,521
6.190%
-70,000decrease
(-2.31%)
Filing
History
2026-05-15
1:26 pm
Purchase
2026-03-3113GMOONLAKE IMMUNOTHERAPEUTICS CO
MLTX
Cormorant Asset Management, LP4,480,433
6.250%
125,000increase
(+2.87%)
Filing
History
2026-05-15
1:22 pm
Purchase
2026-03-3113GIBIO INC PAR $0.001
IBIO
Cormorant Asset Management, LP3,834,335
9.990%
1,586,325increase
(+70.57%)
Filing
History
2026-05-15
1:20 pm
Purchase
2026-03-3113GCABALETTA BIO INC
CABA
Cormorant Asset Management, LP10,500,000
9.030%
1,100,000increase
(+11.70%)
Filing
History
2026-05-15
1:18 pm
Purchase
2026-03-3113GBIOAGE LABS INC
BIOA
Cormorant Asset Management, LP2,890,605
6.510%
850,000increase
(+41.65%)
Filing
History
2026-05-15
1:16 pm
Purchase
2026-03-3113GADLAI NORTYE LTD. SPONSORED AD
ANL
Cormorant Asset Management, LP2,897,857
5.190%
2,897,857increase
(New Position)
Filing
History
2026-05-15
1:14 pm
Purchase
2026-03-3113GAGOMAB THERAPEUTICS NV
AGMB
Cormorant Asset Management, LP2,465,348
5.010%
2,465,348increase
(New Position)
Filing
History
2026-05-15
1:12 pm
Sale
2026-03-3113GENGENE HLDGS INC
ENGN
Cormorant Asset Management, LP0
0.000%
-4,000,000decrease
(Position Closed)
Filing
History
2026-04-30
4:08 pm
Sale
2026-04-2813GBRIGHT MINDS BIOSCIENCES INC C
DRUG
Cormorant Asset Management, LP950,000
9.710%
-109,331decrease
(-10.32%)
Filing
History
2026-02-17
3:02 pm
Sale
2025-12-3113GBIOAGE LABS INC
BIOA
Cormorant Asset Management, LP2,040,605
5.690%
-100,000decrease
(-4.67%)
Filing
History
2026-02-17
3:02 pm
Sale
2025-12-3113GRAPPORT THERAPEUTICS INC
RAPP
Cormorant Asset Management, LP3,027,521
6.350%
-165,000decrease
(-5.17%)
Filing
History
2026-02-17
3:01 pm
Purchase
2025-12-3113GMOONLAKE IMMUNOTHERAPEUTICS CO
MLTX
Cormorant Asset Management, LP4,355,433
6.100%
4,355,433increase
(New Position)
Filing
History
2026-02-17
3:00 pm
Purchase
2025-12-3113GENGENE HLDGS INC
ENGN
Cormorant Asset Management, LP4,000,000
5.970%
4,000,000increase
(New Position)
Filing
History
2026-02-17
3:00 pm
Sale
2025-12-3113GCABALETTA BIO INC
CABA
Cormorant Asset Management, LP9,400,000
9.280%
-191,983decrease
(-2.00%)
Filing
History
2026-02-06
3:00 pm
Unchanged
2026-01-3113GBRIGHT MINDS BIOSCIENCES INC C
DRUG
Cormorant Asset Management, LP1,059,331
10.880%
0
(Unchanged)
Filing
History
2025-12-15
4:19 pm
Sale
2025-12-1113GCORBUS PHARMACEUTICALS HOLDING
CRBP
Cormorant Asset Management, LP2,344,971
13.360%
-30,029decrease
(-1.26%)
Filing
History
2025-12-08
4:06 pm
Sale
2025-12-0413GEYEPOINT INC
EYPT
Cormorant Asset Management, LP8,265,000
9.980%
-60,000decrease
(-0.72%)
Filing
History
2025-11-14
1:23 pm
Unchanged
2025-11-0313GCORBUS PHARMACEUTICALS HOLDING
CRBP
Cormorant Asset Management, LP2,375,000
12.820%
0
(Unchanged)
Filing
History
2025-11-14
1:10 pm
Purchase
2025-09-3013GCABALETTA BIO INC
CABA
Cormorant Asset Management, LP9,591,983
9.990%
4,591,983increase
(+91.84%)
Filing
History
Goto 0, 1, 2, ...6, 7, Next